Clinical profile and outcome of glycogen storage disease in Indian children

Vishrutha Poojari1, Ira Shah1, Naman S Shetty1

  • 1Pediatric Liver Clinic, B. J. Wadia Hospital for Children, Mumbai, India.

Tropical Doctor
|October 27, 2020
PubMed

Insights

This study details the clinical features and outcomes of 36 Indian children with glycogen storage disorders, highlighting common symptoms like abdominal swelling and seizures, and challenging follow-up rates.

Area of Science:

  • Pediatrics
  • Metabolic Disorders
  • Hepatology

Background:

  • Glycogen storage disorders (GSDs) are a group of inherited metabolic diseases affecting glycogen metabolism.
  • Understanding the clinical presentation and long-term outcomes in affected children is crucial for effective management.

Purpose of the Study:

  • To investigate the clinical profile and outcomes of Indian children diagnosed with glycogen storage disorders.
  • To identify common presenting symptoms, complications, and treatment responses in this cohort.

Main Methods:

  • Retrospective analysis of 36 children diagnosed with GSDs via liver biopsy between 2005 and 2018.
  • Review of clinical data including presenting symptoms, biochemical parameters, and follow-up information.

Main Results:

  • Abdominal swelling was the most common presentation (77.7%), followed by convulsions (25%).
  • Associated symptoms included hypoglycemia, developmental delay, diarrhea, ascites, and portal hypertension.
  • Complications observed during follow-up included recurrent seizures, neutropenia, infections, nephrocalcinosis, and liver adenoma.
  • Liver function showed improvement in 37.5% of patients, with normalization of triglycerides and transaminases in some.

Conclusions:

  • Glycogen storage disorders in Indian children present with diverse clinical features, often including hepatomegaly and hypoglycemia.
  • Significant challenges exist in patient follow-up, impacting the assessment of long-term outcomes.
  • Early diagnosis and comprehensive management are essential to mitigate complications and improve outcomes in pediatric GSDs.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
595
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
26.8K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.7K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
2.7K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.5K